BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 23006631)

  • 1. The effectiveness of single-dose fosfomycin as antimicrobial prophylaxis for patients undergoing transrectal ultrasound-guided biopsy of the prostate.
    Ongün S; Aslan G; Avkan-Oguz V
    Urol Int; 2012; 89(4):439-44. PubMed ID: 23006631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re: the effectiveness of single-dose fosfomycin as antimicrobial prophylaxis for patients undergoing transrectal ultrasound-guided biopsy of the prostate.
    Schaeffer EM
    J Urol; 2014 Feb; 191(2):361-2. PubMed ID: 24411855
    [No Abstract]   [Full Text] [Related]  

  • 3. Antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: fosfomycin trometamol, an attractive alternative.
    Cai T; Gallelli L; Cocci A; Tiscione D; Verze P; Lanciotti M; Vanacore D; Rizzo M; Gacci M; Saleh O; Malossini G; Liguori G; Trombetta C; Rocco D; Palmieri A; Bartoletti R; Carini M; Wagenlehner FM; Naber K; Mirone V; Bjerklund Johansen TE
    World J Urol; 2017 Feb; 35(2):221-228. PubMed ID: 27246847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of single-dose fosfomycin as antimicrobial prophylaxis in transrectal ultrasound-guided biopsy of the prostate.
    Garg M; Singh V; Sankhwar SN
    Urol Int; 2013; 91(1):124. PubMed ID: 23751859
    [No Abstract]   [Full Text] [Related]  

  • 5. Fosfomycin vs. quinolone-based antibiotic prophylaxis for transrectal ultrasound-guided biopsy of the prostate: a systematic review and meta-analysis.
    Noreikaite J; Jones P; Fitzpatrick J; Amitharaj R; Pietropaolo A; Vasdev N; Chadwick D; Somani BK; Rai BP
    Prostate Cancer Prostatic Dis; 2018 Jun; 21(2):153-160. PubMed ID: 29487398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of fosfomycin against fluoroquinolones for transrectal prostate biopsy prophylaxis: an individual patient-data meta-analysis.
    Roberts MJ; Scott S; Harris PN; Naber K; Wagenlehner FME; Doi SAR
    World J Urol; 2018 Mar; 36(3):323-330. PubMed ID: 29288398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Single and Prolonged Fluoroquinolone Prophylaxis and Risk Factors for Infectious Complications After Transrectal Prostate Biopsy.
    Kalkanlı A; Gezmiş CT; Özkan A; Çilesiz NC; Yanaral F; Aydın M; Tandoğdu Z
    Balkan Med J; 2018 Sep; 35(5):373-377. PubMed ID: 29866640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fosfomycin for Antibiotic Prophylaxis in Men Undergoing a Transrectal Prostate Biopsy: A Systematic Review and Meta-Analysis.
    Gu HM; Gu JS; Chung HS; Jung SI; Kwon D; Kim MH; Jung JH; Han MA; Kang SJ; Hwang EC; Dahm P
    Medicina (Kaunas); 2023 May; 59(5):. PubMed ID: 37241143
    [No Abstract]   [Full Text] [Related]  

  • 9. For Single Dosing, Levofloxacin Is Superior to Ciprofloxacin When Combined With an Aminoglycoside in Preventing Severe Infections After Prostate Biopsy.
    Unnikrishnan R; El-Shafei A; Klein EA; Jones JS; Kartha G; Goldman HB
    Urology; 2015 Jun; 85(6):1241-6. PubMed ID: 25863835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of fosfomycin compared to second generation cephalosporin flumarin as antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: a single center retrospective study.
    Kim HY; Lim D; Choi YH; Yoo JM; Lee DS; Lee SJ
    BMC Urol; 2023 Dec; 23(1):211. PubMed ID: 38114968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of fosfomycin tromethamine prophylaxis in preventing infection following transrectal ultrasound-guided prostate needle biopsy: Results from a large Canadian cohort.
    Carignan A; Sabbagh R; Masse V; Gagnon N; Montpetit LP; Smith MA; Raymond M; Allard C; Bergeron C; Pépin J
    J Glob Antimicrob Resist; 2019 Jun; 17():112-116. PubMed ID: 30553114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective culture of Escherichia coli to prevent infective complications of transrectal ultrasound-guided prostate biopsy: Clinical efficacy and analysis of characteristics of quinolone-resistant Escherichia coli.
    Hiyama Y; Takahashi S; Uehara T; Ichihara K; Hashimoto J; Matsukawa M; Taguchi K; Kunishima Y; Hotta H; Yanase M; Itoh N; Hirose T; Takeyama K; Tachiki H; Masumori N
    Int J Urol; 2019 Jun; 26(6):655-660. PubMed ID: 30959574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complication Rate After Antibiotic Prophylaxis with Fosfomycin Versus Fluorochinolones or β-lactam Antibiotics in Patients Undergoing Prostate Biopsy: A Propensity Score-adjusted Analysis.
    Cimino S; Verze P; Venturino L; Alessio P; Migliara A; Imbimbo C; Mirone V; Russo GI; Morgia G
    Eur Urol Focus; 2020 Mar; 6(2):370-375. PubMed ID: 30007542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of fosfomycin-trometamol in the prophylaxis for transrectal prostate biopsy. Prospective randomized comparison with ciprofloxacin.
    Lista F; Redondo C; Meilán E; García-Tello A; Ramón de Fata F; Angulo JC
    Actas Urol Esp; 2014; 38(6):391-6. PubMed ID: 24775812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Prospective Randomized Trial Comparing a Combined Regimen of Amikacin and Levofloxacin to Levofloxacin Alone as Prophylaxis in Transrectal Prostate Needle Biopsy.
    Miyazaki Y; Akamatsu S; Kanamaru S; Kamiyama Y; Sengiku A; Iguchi R; Sano T; Takahashi A; Ito M; Takenawa J; Ito N; Ogura K
    Urol J; 2016 Mar; 13(1):2533-40. PubMed ID: 26945658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of levofloxacin-based prophylaxis regimens for transrectal prostate biopsy: a prospective randomized single-center study.
    Su R; Wang KY; Zhang D; Yan ZJ; Jiang JH; Ma Q
    Eur J Clin Microbiol Infect Dis; 2019 May; 38(5):967-971. PubMed ID: 30919151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of prophylactic single-dose fosfomycin in patients who undergo transrectal ultrasound-guided prostate biopsy: A prospective, randomized, and controlled clinical study.
    Sen V; Aydogdu O; Bozkurt IH; Yonguc T; Sen P; Polat S; Degirmenci T; Bolat D
    Can Urol Assoc J; 2015; 9(11-12):E863-7. PubMed ID: 26788236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound guided prostate biopsy is associated with reduced incidence of postoperative infectious complications and cost of care.
    Taylor AK; Zembower TR; Nadler RB; Scheetz MH; Cashy JP; Bowen D; Murphy AB; Dielubanza E; Schaeffer AJ
    J Urol; 2012 Apr; 187(4):1275-9. PubMed ID: 22341272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fosfomycin-trometamol (FT) or fluoroquinolone (FQ) as single-dose prophylaxis for transrectal ultrasound-guided prostate biopsy (TRUS-PB): A prospective cohort study.
    Delory T; Goujon A; Masson-Lecomte A; Arias P; Laurancon-Fretar A; Bercot B; Mongiat-Artus P; Molina JM; Lafaurie M
    Int J Infect Dis; 2021 Jan; 102():269-274. PubMed ID: 33129963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levofloxacin resistant Escherichia coli sepsis following an ultrasound-guided transrectal prostate biopsy: report of four cases and review of the literature.
    Miura T; Tanaka K; Shigemura K; Nakano Y; Takenaka A; Fujisawa M
    Int J Urol; 2008 May; 15(5):457-9. PubMed ID: 18452466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.